July 31, 2013

Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

July 30, 2013

Attendees of this year’s Cardinal Health Retail Business Conference will choose 1-of-3 finalists of a special best practice competition to determine the most innovative independent pharmacy program among Cardinal Health customers.

July 23, 2013

The Pharmacy Quality Alliance is supporting medication synchronization programs and pilots at pharmacies around the country using an appointment-based model, saying the model focuses on aligning drug refills of chronic medications to fall upon the same appointment date each month, the group said Tuesday.

July 22, 2013

Cardinal Health and the National Association of Chain Drug Stores Foundation are calling for proposals to research the effects of pharmacist-provided medication therapy management services on hospital readmission rates.

Medications only do their jobs if patients take them as instructed by physicians, but physicians' ability to ensure that patients are doing what they're supposed to is limited. That's where pharmacists can step in to help make a difference.

July 18, 2013

According to the Administration on Aging, the United States is similar to many other countries in the developed world — and even a few in the developing world — in that the population is getting older.

July 17, 2013

Biomed Pharmaceuticals has appointed Gaston Bernstein as CEO, the maker of injectable and intravenous drugs for patients with chronic disorders said.

July 16, 2013

The National Community Pharmacists Association CEO Douglas Hoey testified Tuesday before the U.S. House of Representatives Energy and Commerce Subcommittee on Health’s hearing on “Reforming the Drug Compounding Regulatory Framework.”

July 12, 2013

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

July 10, 2013

Many patients are not complying with their prescription drug therapies due to adverse side effects, even though some OTC drugs can treat them, according to a new study commissioned by a maker of products for dry mouth, one of the most common medication side effects.

July 9, 2013

With some studies showing that patients' failure to take their medications as directed costs the economy nearly $300 billion per year, one group is looking to tackle what it sees as part of the problem: doctors' and pharmacists' instructions to patients on how much medicine to take and when.

July 8, 2013

Amid mounting evidence of the negative clinical and economic consequences of medication nonadherence, research featured on the cover of this month’s Health Affairs breaks new ground by urging innovative approaches to improve medication adherence and to “achieve a higher-performing health system.”

July 2, 2013

Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.

June 27, 2013

Onco360 is joining the limited-distribution network for two newly approved cancer drugs made by GlaxoSmithKline, the specialty pharmacy company said.

June 25, 2013

It appears that medication adherence among Americans age 40 years and older ranges from mediocre to worse, according to a new report by a trade group representing independent pharmacies.

June 19, 2013

Target Corp. is reaching out to Canadian customers preparing to send their children to summer camp with information and resources about allergies.

June 12, 2013

More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.

June 11, 2013

The emergency contraceptive Plan B (the original two-tablet formulation) can now be sold as an OTC without any sales restrictions as the Obama administration concedes its fight to prevent nonprescription access to younger teenage girls. And soon the newer Plan B One Step (one tablet) will be available without sales restrictions as well.

June 4, 2013

A lot is said about how pharmacists are the most accessible healthcare professionals, and one health insurer is taking advantage of this by sponsoring a series of special seminars for elderly people.

June 4, 2013

A subsidiary of Aceto Corp. has launched a generic treatment for seasonal and perennial allergies, the company said Tuesday.

May 22, 2013

Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.

May 21, 2013

Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.

May 9, 2013

One of the difficulties that federal regulators ran into during the nationwide scandal surrounding the New England Compounding Center — the Massachusetts-based pharmacy blamed for a nationwide fungal meningitis epidemic that has sickened hundreds and killed dozens — was the issue of when such pharmacies cross the line from compounding to manufacturing.

May 8, 2013

There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday.

May 6, 2013

Pfizer is attempting to stem the rise of counterfeit medicines by selling one of its most popular drugs — and one of the most popular targets for counterfeiters — online.